Answers are grounded in this paper and cite their sources.
To the Editor:The Sjögren's Foundation applauds the American College of Rheumatology (ACR) and the American College of Chest Physicians (CHEST) for their multispecialty collaboration in developing clinical practice guidelines (CPGs) for autoimmune disease-related interstitial lung diseases.1 We would like to note that the Sjögren's Foundation pulmonary guidelines 2 expand on one of the autoimmune diseases included in this publication, Sjögren disease.Our guidelines, which complement the ACR/CHEST guidelines, involved multispecialty collaboration across pulmonology, rheumatology, and oncology as well as patient input at every stage.CPGs play a vital role in standardizing care by ensuring a unified set of minimum criteria for patient management and highlight needed research.Such guidelines also aid in securing appropriate diagnostic and treatment modalities from insurance providers, making them a critical element in improving patient outcomes.As widely referenced and used tools by clinicians, CPGs have the potential for significant impact on patient health.Given their importance, it is essential to provide the most comprehensive expert guidance possible to inform day-to-day clinical decisionmaking.Exploring alternative methodologies that maintain high standards while reducing the burden on contributors could accelerate the development and release of new CPGs.3,4 Patient advocacy organizations (PAGs) serve as trusted sources of information within their respective communities and often have content experts on their leadership teams.We commend professional societies, such as ACR and CHEST, for leading efforts to create CPGs.However, it is unlikely that these societies alone will be able to address every management dilemma across all conditions.By partnering with PAGs, gaps in CPG development can be filled more efficiently, ensuring both timely creation and regular updates as new evidence emerges.Disease-specific organizations bring added value that further patient and provider disease-centric expertise.The involvement of PAGs in the CPG development process, or at least endorsement of the CPGs by the respective PAGs, might also help increase clinical uptake of the guidelines.We support increased PAG consideration of incorporating the creation and updating of CPGs into their organizations' missions and call on professional societies to actively engage PAGs throughout the CPG development process.The authors below are members of the Topic Review Group for the Sjögren's Foundation Clinical Practice Guidelines, Pulmonary Manifestations of Sjögren's.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: